New kidney Drug's heart risk tested in 24 healthy volunteers
NCT ID NCT07470177
First seen Mar 18, 2026 · Last updated May 12, 2026 · Updated 11 times
Summary
This early-stage study checks whether a single dose of JMKX003142, a drug being developed for polycystic kidney disease, affects the heart's electrical activity. It involves 24 healthy Chinese adults who will receive either the drug or a placebo. The goal is to ensure the drug is safe for the heart before moving to larger studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADPKD (AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE) are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.